U.S. RESEARCH ROUNDUP-CAVA Group, Eagle Materials, Vertiv
Bright Minds Biosciences DRUG | 0.00 | |
Alphabet A GOOGL | 0.00 | |
CVS Health CVS | 0.00 | |
Ionis Pharmaceuticals IONS | 0.00 | |
Elevance Health ELV | 0.00 |
May 20 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including CAVA Group, Eagle Materials and Vertiv Holdings, on Wednesday.
HIGHLIGHTS
* CAVA Group Inc CAVA.N: Jefferies raises target price to $95 from $85 |
* CH Robinson Worldwide Inc CHRW.O: Jefferies raises to buy from hold |
* Eagle Materials Inc EXP.N: JP Morgan raises target price to $225 from $215 |
* Moderna MRNA.O: JP Morgan resumes coverage with underweight rating; price target $40 |
* Vertiv Holdings Co VRT.N: TD Cowen raises target price to $387 from $347 |
Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.
* Alnylam Pharmaceuticals Inc ALNY.O: JP Morgan resumes coverage with overweight rating |
* Alnylam Pharmaceuticals Inc ALNY.O: JP Morgan resumes coverage with PT $420 |
* Alphabet Inc GOOGL.O: Wells Fargo raises target price to $435 from $427 |
* Amazon.Com Inc AMZN.O: Wells Fargo cuts target price to $312 from $313 |
* Amneal Pharmaceuticals AMRX.O: Barclays raises target price to $16 from $15 |
* Apa Corporation APA.O: Citigroup raises target price to $44 from $40 |
* Biomarin Pharmaceutical Inc BMRN.O: JP Morgan resumes coverage with overweight rating; PT $80 |
* Bright Minds Biosciences Inc DRUG.N: Piper Sandler raises target price to $220 from $190 |
* Brown & Brown Inc BRO.N: JP Morgan cuts target price to $81 from $85 |
* Brown-Forman Corp BFb.N: Citigroup cuts target price to $26 from $31 |
* Cactus Inc WHD.N: Stifel raises target price to $66 from $59 |
* California Resources Corp CRC.N: Citigroup raises to buy from neutral |
* California Resources Corp CRC.N: Citigroup raises target price to $78 from $74 |
* Cava Group Inc CAVA.N: Barclays raises target price to $74 from $70 |
* CAVA Group Inc CAVA.N: Bernstein raises target price to $95 from $84 |
* CAVA Group Inc CAVA.N: Jefferies raises target price to $95 from $85 |
* CAVA Group Inc CAVA.N: Mizuho raises target price to $85 from $80 |
* CAVA Group Inc CAVA.N: Piper Sandler raises target price to $92 from $85 |
* CAVA Group Inc CAVA.N: Stifel raises target price to $105 from $90 |
* CAVA Group Inc CAVA.N: Telsey Advisory Group raises target price to $95 from $92 |
* Centene Corp CNC.N: Mizuho raises target price to $58 from $50 |
* CH Robinson Worldwide Inc CHRW.O: Jefferies raises PT to $200 from $195 |
* CH Robinson Worldwide Inc CHRW.O: Jefferies raises to buy from hold |
* Crowdstrike CRWD.O: Stifel raises target price to $660 from $480 |
* CVS Health Corp CVS.N: Mizuho raises target price to $110 from $102 |
* Devon Energy Corp DVN.N: Citigroup raises target price to $65 from $60 |
* Diamondback Energy Inc FANG.O: Citigroup raises target price to $245 from $225 |
* Dick's Sporting Goods Inc DKS.N: Telsey Advisory Group raises target price to $255 from $240 |
* Eagle Materials Inc EXP.N: JP Morgan raises target price to $225 from $215 |
* Eagle Materials Inc EXP.N: RBC raises target price to $219 from $208 |
* Eagle Materials Inc EXP.N: Stephens cuts target price to $225 from $235 |
* eBay EBAY.O: Bernstein raises target price to $100 from $95 |
* Elevance Health ELV.N: Mizuho raises target price to $435 from $385 |
* EOG Resources Inc EOG.N: Citigroup raises target price to $147 from $142 |
* Halozyme Therapeutics Inc HALO.O: JP Morgan resumes coverage with neutral rating; PT $70 |
* Hershey HSY.N: Mizuho cuts target price to $185 from $195 |
* Home Depot Inc HD.N: Bernstein cuts target price to $346 from $365 |
* Home Depot Inc HD.N: D.A. Davidson cuts target price to $377 from $445 |
* Home Depot Inc HD.N: Jefferies cuts target price to $361 from $454 |
* Home Depot Inc HD.N: JP Morgan cuts target price to $396 from $423 |
* Home Depot Inc HD.N: Mizuho cuts target price to $385 from $415 |
* Home Depot Inc HD.N: Piper Sandler cuts target price to $378 from $421 |
* Home Depot Inc HD.N: Wells Fargo cuts target price to $360 from $375 |
* Home Depot Inc HD.N: RBC cuts target price to $340 from $377 |
* Home Depot Inc HD.N: Telsey Advisory Group cuts target price to $410 from $435 |
* Humana HUM.N: Mizuho raises target price to $335 from $290 |
* Incyte INCY.O: JP Morgan resumes coverage with neutral rating; price target $105 |
* Insmed Inc INSM.O: JP Morgan resumes coverage with overweight rating; price target $180 |
* Ionis Pharmaceuticals Inc IONS.O: JP Morgan resumes coverage with overweight rating; PT $90 |
* Jazz Pharmaceuticals Plc JAZZ.O: JP Morgan resumes coverage with overweight rating; PT $265 |
* Keysight Technologies Inc KEYS.N: Susquehanna raises target price to $425 from $415 |
* Keysight Technologies Inc KEYS.N: Wells Fargo raises target price to $390 from $300 |
* KLA Corp KLAC.O: Bernstein raises target price to $1,975 from $1,875 |
* Lam Research LRCX.O: Bernstein raises target price to $340 from $325 |
* Lumexa Imaging Holdings Inc LMRI.O: Barclays cuts target price to $9 from $15 |
* Marvell Technology Inc MRVL.O: Wells Fargo raises target price to $195 from $135 |
* Meta Platforms Inc META.O: Wells Fargo cuts target price to $765 from $770 |
* Mirum Pharmaceuticals MIRM.O: JP Morgan resumes coverage with overweight rating; PT $115 |
* Moderna MRNA.O: JP Morgan resumes coverage with underweight rating; price target $40 |
* Ovintiv Inc OVV.N: Citigroup raises to buy from neutral; raises PT to $70 from $62 |
* Palo Alto Networks Inc PANW.O: Stifel raises target price to $275 from $185 |
* Phreesia Inc PHR.N: Wells Fargo cuts target price to $9 from $15 |
* Phreesia Inc PHR.N: Wells Fargo cuts to equal weight from overweight |
* Quicklogic Corp QUIK.O: Needham initiates coverage with buy rating; target price $22 |
* Radnet RDNT.O: Barclays cuts target price to $65 from $70 |
* Relay Therapeutics Inc RLAY.O: Leerink Partners raises target price to $29 from $23 |
* Relay Therapeutics Inc. RLAY.O: Barclays raises target price to $27 from $21 |
* Semtech Corp SMTC.O: Susquehanna raises target price to $170 from $110 |
* Sentinelone Inc S.N: Barclays raises target price to $19 from $16 |
* Snowflake Inc SNOW.N: Benchmark raises target price to $200 from $190 |
* Synaptics Inc SYNA.O: Rosenblatt Securities raises target price to $180 from $125 |
* Tenet Healthcare Corp THC.N: JP Morgan cuts target price to $260 from $280 |
* United Therapeutics Corp UTHR.O: JP Morgan resumes coverage with overweight rating; PT $685 |
* UnitedHealth UNH.N: Mizuho raises target price to $440 from $410 |
* Universal Health Services Inc UHS.N: JP Morgan cuts target price to $205 from $235 |
* Vertex Pharmaceuticals VRTX.O: JP Morgan resumes coverage with overweight rating; PT $515 |
* Vertiv Holdings Co VRT.N: TD Cowen raises target price to $387 from $347 |
* Wayfair Inc W.N: Bernstein cuts target price to $85 from $100 |
* Waystar Holding Corp WAY.O: Barclays cuts target price to $25 from $36 |
* Xponential Fitness Inc XPOF.N: Northland Capital raises to outperform from market perform |
* Xponential Fitness Inc XPOF.N: Northland Capital cuts target price to $8 from $9 |
* Zscaler Inc ZS.O: Citigroup raises target price to $205 from $195 |